INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 125 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $9,000 | -10.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $10,000 | -16.7% | 2,500 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $12,000 | +20.0% | 2,500 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $10,000 | -16.7% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | +20.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $10,000 | -37.5% | 2,500 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $16,000 | -20.0% | 2,500 | 0.0% | 0.01% | -25.0% |
| Q2 2017 | $20,000 | +17.6% | 2,500 | 0.0% | 0.01% | +14.3% |
| Q1 2017 | $17,000 | -15.0% | 2,500 | -13.0% | 0.01% | -22.2% |
| Q4 2016 | $20,000 | -25.9% | 2,875 | 0.0% | 0.01% | -30.8% |
| Q3 2016 | $27,000 | 0.0% | 2,875 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $27,000 | +8.0% | 2,875 | 0.0% | 0.01% | +8.3% |
| Q1 2016 | $25,000 | +31.6% | 2,875 | 0.0% | 0.01% | +50.0% |
| Q4 2015 | $19,000 | – | 2,875 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |